Data / Drug companies / Lannett Company, Inc.
Lannett Company, Inc.: 29 products in the FDA NDC directory, labeler code 62175
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lannett Company, Inc. (labeler code 62175) lists 29 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 29 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 1, 2017.
The request: Watch Lannett Company, Inc. (FDA labeler code 62175): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62175
- Products in commercial distribution
- 29
- Packages
- 68
- Finished drugs by generic name
- 12
- Prescription products
- 29
- Over the counter products
- 0
- Controlled substance products
- Schedule II 4, Schedule III 2
- Flagged as original packager
- 26 of 26 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 30, 1993
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 27 | 93.1% |
| Authorized generics (NDA) | 2 | 6.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 29 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Methylphenidate hydrochloride | 4 | 39 |
| Nifedipine | 3 | 38 |
| Omeprazole | 3 | 106 |
| Oxybutynin chloride | 3 | 45 |
| Paroxetine hydrochloride | 3 | 16 |
| Niacin | 2 | 13 |
| Pantoprazole sodium | 2 | 54 |
| Isosorbide mononitrate | 2 | 25 |
| Esomeprazole magnesium | 2 | 77 |
| Buprenorphine and naloxone | 2 | 22 |
| Montelukast sodium | 2 | 31 |
| Rabeprazole sodium | 1 | 20 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 9 | 31% |
| Tablet, film coated, extended release | 6 | 20.7% |
| Tablet | 4 | 13.8% |
| Tablet, delayed release | 3 | 10.3% |
| Capsule, delayed release | 3 | 10.3% |
| Capsule, delayed release pellets | 2 | 6.9% |
| Tablet, chewable | 2 | 6.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Esomeprazole Magnesium | 62175-840 | Capsule, delayed release pellets | Generic drugs (ANDA) | September 1, 2017 |
| Esomeprazole Magnesium | 62175-820 | Capsule, delayed release pellets | Generic drugs (ANDA) | September 1, 2017 |
| Niacin | 62175-322 | Tablet, extended release | Generic drugs (ANDA) | February 16, 2017 |
| Niacin | 62175-320 | Tablet, extended release | Generic drugs (ANDA) | February 16, 2017 |
| Buprenorphine and Naloxone | 62175-458 | Tablet | Generic drugs (ANDA) | September 19, 2016 |
| Buprenorphine and Naloxone | 62175-452 | Tablet | Generic drugs (ANDA) | September 19, 2016 |
| Paroxetine Hydrochloride | 62175-472 | Tablet, film coated, extended release | Generic drugs (ANDA) | October 31, 2014 |
| Paroxetine Hydrochloride | 62175-471 | Tablet, film coated, extended release | Generic drugs (ANDA) | October 31, 2014 |
| Paroxetine Hydrochloride | 62175-470 | Tablet, film coated, extended release | Generic drugs (ANDA) | October 31, 2014 |
| Rabeprazole Sodium | 62175-302 | Tablet, delayed release | Generic drugs (ANDA) | November 8, 2013 |
| Methylphenidate Hydrochloride | 62175-313 | Tablet, extended release | Generic drugs (ANDA) | September 23, 2013 |
| Methylphenidate Hydrochloride | 62175-312 | Tablet, extended release | Generic drugs (ANDA) | September 23, 2013 |
| Methylphenidate Hydrochloride | 62175-311 | Tablet, extended release | Generic drugs (ANDA) | July 10, 2013 |
| Methylphenidate Hydrochloride | 62175-310 | Tablet, extended release | Generic drugs (ANDA) | July 10, 2013 |
| Montelukast Sodium | 62175-205 | Tablet, chewable | Generic drugs (ANDA) | August 3, 2012 |
| Montelukast Sodium | 62175-204 | Tablet, chewable | Generic drugs (ANDA) | August 3, 2012 |
| Pantoprazole Sodium | 62175-618 | Tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Pantoprazole Sodium | 62175-617 | Tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Oxybutynin Chloride Extended Release | 62175-272 | Tablet, extended release | Generic drugs (ANDA) | March 1, 2009 |
| Oxybutynin Chloride Extended Release | 62175-271 | Tablet, extended release | Generic drugs (ANDA) | March 1, 2009 |
| Oxybutynin Chloride Extended Release | 62175-270 | Tablet, extended release | Generic drugs (ANDA) | March 1, 2009 |
| Omeprazole | 62175-136 | Capsule, delayed release | Generic drugs (ANDA) | January 23, 2009 |
| Nifedipine | 62175-262 | Tablet, film coated, extended release | Generic drugs (ANDA) | October 3, 2007 |
| Nifedipine | 62175-261 | Tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2005 |
| Nifedipine | 62175-260 | Tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2005 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.